Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

NCT02399345 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus (HCV Infection Genotype 1)

Interventions

DRUG: ombitasvir/paritaprevir/ritonavir, dasabuvir
DRUG: sofosbuvir (SOF)
DRUG: ribavirin (RBV)

Sponsor

AbbVie